Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Stent Technology is a Japanese medical device company specializing in the development and production of high-performance coronary stents. The company is widely recognized for its innovation in drug-eluting stent (DES) technology, particularly its use of bioresorbable polymers and abluminal coating techniques designed to promote faster vascular healing. Its flagship product, the Nobori stent, was developed in partnership with Terumo Corporation and has achieved significant commercial success in international markets. Founded in 2003 as a spin-off from Okayama University, the company established itself as a leader in cardiovascular intervention R&D. In 2016, Terumo Corporation acquired the remaining shares of the company, fully integrating its operations and technology into Terumo's vascular intervention division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Stent Technology.